Literature DB >> 23848957

LR11: a novel biomarker identified in follicular lymphoma.

Takeharu Kawaguchi1, Chikako Ohwada, Masahiro Takeuchi, Naomi Shimizu, Emiko Sakaida, Yusuke Takeda, Shio Sakai, Shokichi Tsukamoto, Atsuko Yamazaki, Yasumasa Sugita, Meizi Jiang, Morihiro Higashi, Koutaro Yokote, Jun-ichi Tamaru, Hideaki Bujo, Chiaki Nakaseko.   

Abstract

Entities:  

Keywords:  FLIPI-2; LR11; biomarker; follicular lymphoma; progression free survival

Mesh：

Substances：

Year:  2013        PMID： 23848957     DOI： 10.1111/bjh.12467

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.

Authors:  Patryk Krzeminski; Luis A Corchete; Juan L García; Lucía López-Corral; Encarna Fermiñán; Eva M García; Ana A Martín; Jesús M Hernández-Rivas; Ramón García-Sanz; Jesús F San Miguel; Norma C Gutiérrez
Journal:  Oncotarget       Date:  2016-12-06

2.  Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer.

Authors:  Yajing Xu; Didi Chen; Lanxiao Shen; Xiaowei Huang; Yi Chen; Huafang Su
Journal:  Front Genet       Date:  2021-12-16       Impact factor: 4.599

Review 3.  Low-Density Lipoprotein Receptor-Related Protein 8 at the Crossroad between Cancer and Neurodegeneration.

Authors:  Daniela Passarella; Silvia Ciampi; Valentina Di Liberto; Mariachiara Zuccarini; Maurizio Ronci; Alessandro Medoro; Emanuele Foderà; Monica Frinchi; Donatella Mignogna; Claudio Russo; Carola Porcile
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

4.  Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Takeharu Kawaguchi; Emi Togasaki; Atsuko Yamazaki; Yasumasa Sugita; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Keigo Nishii; Meizi Jiang; Koutaro Yokote; Hideaki Bujo; Chiaki Nakaseko
Journal:  Exp Mol Med       Date:  2014-04-04       Impact factor: 8.718
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.